Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myeloid Cell Reprogramming in the Context of Radioiodine Therapy in Patients With Non-Medullary Thyroid Carcinoma

NCT03397238 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT03397238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03397238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myeloid Cell Reprogramming in the Context of Radioiodine Therapy in Patients With Non-Medullary Thyroid Carcinoma
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
March 6, 2018
Completion date
January 5, 2021
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer